Literature DB >> 32669307

Intensive Blood Pressure Lowering Should Be the Goal for Most Individuals at High Risk of Cardiovascular Disease Irrespective of Albuminuria.

Simon B Ascher1,2, Joachim H Ix3,4.   

Abstract

Entities:  

Keywords:  hypertension; albuminuria; blood pressure; cardiovascular disease; chronic kidney disease; proteinuria; randomized controlled trials

Year:  2020        PMID： 32669307      PMCID： PMC7409762          DOI： 10.2215/CJN.09410620

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.

Authors:  Andrew S Levey; Ron T Gansevoort; Josef Coresh; Lesley A Inker; Hiddo L Heerspink; Morgan E Grams; Tom Greene; Hocine Tighiouart; Kunihiro Matsushita; Shoshana H Ballew; Yingying Sang; Edward Vonesh; Jian Ying; Tom Manley; Dick de Zeeuw; Kai-Uwe Eckardt; Adeera Levin; Vlado Perkovic; Luxia Zhang; Kerry Willis
Journal:  Am J Kidney Dis       Date:  2019-08-28       Impact factor: 8.860

2.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

Review 3.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.

Authors:  Jicheng Lv; Parya Ehteshami; Mark J Sarnak; Hocine Tighiouart; Min Jun; Toshiharu Ninomiya; Celine Foote; Anthony Rodgers; Hong Zhang; Haiyan Wang; Giovanni F M Strippoli; Vlado Perkovic
Journal:  CMAJ       Date:  2013-06-24       Impact factor: 8.262

4.  Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Authors:  William R Zhang; Timothy E Craven; Rakesh Malhotra; Alfred K Cheung; Michel Chonchol; Paul Drawz; Mark J Sarnak; Chirag R Parikh; Michael G Shlipak; Joachim H Ix
Journal:  Ann Intern Med       Date:  2018-10-23       Impact factor: 25.391

5.  Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Authors:  Rakesh Malhotra; Timothy Craven; Walter T Ambrosius; Anthony A Killeen; William E Haley; Alfred K Cheung; Michel Chonchol; Mark Sarnak; Chirag R Parikh; Michael G Shlipak; Joachim H Ix
Journal:  Am J Kidney Dis       Date:  2018-10-02       Impact factor: 8.860

6.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

7.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

8.  Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.

Authors:  Srinivasan Beddhu; Jincheng Shen; Alfred K Cheung; Paul L Kimmel; Glenn M Chertow; Guo Wei; Robert E Boucher; Michel Chonchol; Farid Arman; Ruth C Campbell; Gabriel Contreras; Jamie P Dwyer; Barry I Freedman; Joachim H Ix; Kent Kirchner; Vasilios Papademetriou; Roberto Pisoni; Michael V Rocco; Paul K Whelton; Tom Greene
Journal:  J Am Soc Nephrol       Date:  2019-07-19       Impact factor: 10.121

9.  Effects of Intensive BP Control in CKD.

Authors:  Alfred K Cheung; Mahboob Rahman; David M Reboussin; Timothy E Craven; Tom Greene; Paul L Kimmel; William C Cushman; Amret T Hawfield; Karen C Johnson; Cora E Lewis; Suzanne Oparil; Michael V Rocco; Kaycee M Sink; Paul K Whelton; Jackson T Wright; Jan Basile; Srinivasan Beddhu; Udayan Bhatt; Tara I Chang; Glenn M Chertow; Michel Chonchol; Barry I Freedman; William Haley; Joachim H Ix; Lois A Katz; Anthony A Killeen; Vasilios Papademetriou; Ana C Ricardo; Karen Servilla; Barry Wall; Dawn Wolfgram; Jerry Yee
Journal:  J Am Soc Nephrol       Date:  2017-06-22       Impact factor: 10.121

10.  Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Post Hoc Analyses from SPRINT.

Authors:  Alex R Chang; Holly Kramer; Guo Wei; Robert Boucher; Morgan E Grams; Dan Berlowitz; Udayan Bhatt; Debbie L Cohen; Paul Drawz; Henry Punzi; Barry I Freedman; William Haley; Amret Hawfield; Edward Horwitz; Christopher McLouth; Don Morisky; Vasilios Papademetriou; Michael V Rocco; Barry Wall; Daniel E Weiner; Athena Zias; Srinivasan Beddhu
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-15       Impact factor: 8.237
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.